初期前立腺がんおよびCTCにおける抗腫瘍免疫遺伝子の静止作用
Hongshan Guo1, Joanna A Vuille2, Ben S Wittner2
1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Cell
|June 16, 2023
まとめ
前立腺がんの初期段階では 免疫遺伝子のCD1やIFI16を 静止させることで DNAの低甲基化が起こります これらの遺伝子をマウスで再活性化することで 腫瘍の成長が止まり 癌に対する免疫の表遺伝子が 明らかになりました
科学分野:
- ゲノム表遺伝学
- 癌の生物学
- 免疫学
背景:
- 癌はDNA低甲基化を示し,大きなクロマチンのドメインで遺伝子を静止させるが,腫瘍発生におけるその役割は不明である.
- 前立腺の悪性腫瘍の進行には,DNAメチル化変化を含む表遺伝的変化が含まれます.
研究 の 目的:
- 前立腺がんにおける早期DNA低甲基化ドメインの特定と特徴づけ
- これらの低メチル化ドメインの遺伝子静止と腫瘍発生における役割を調査する.
- これらの遺伝的変化をがん治療の標的とする可能性を 探求する.
主な方法:
- 高解像度,全ゲノム,単細胞DNAメチル化のシーケンス
- 早期前立腺悪性腫瘍から転移性循環腫瘍細胞 (CTC) までのDNAメチル化パターンの分析.
- 免疫能力のあるマウスモデルでの遺伝子発現分析と機能研究.
主要な成果:
- 初期前立腺がんから転移したCTCまで,均等に存在する40の核低甲基化ドメインを特定した.
- CD1およびインターフェロン誘導性遺伝子 (IFI16) を含む,これらのドメイン内の静止された遺伝子が,免疫関連の遺伝子を豊かにしていることが発見されました.
- マウスにおけるCD1またはIFI16オートログの再発が腫瘍形成を無効化し,抗腫瘍免疫を活性化することが示された.
結論:
- 初期のエピジェネティック変化,特にDNA低甲基化ドメインは 重要な免疫遺伝子を静止することによって 腫瘍発生を大きく形作る.
- これらの発見は,特定の表遺伝子変異を標的とするのが癌の免疫療法にとって有効な戦略である可能性があることを示唆している.
- 低メチル化ドメインは血液で検出され,CTCによる非侵襲的な癌検出の可能性を提供します.
関連する概念動画
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


